Various metabolic abnormalities in the form of impaired glucose, fatty acid, and amino acid metabolism (and more) with concomitant endocrine dysregulation are also found in SMA patients; this may also result from the denervation process and from the lack of SMN protein [10,14,15,35,36]. The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.